Roman Butler Fullerton & Co’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-2,867
Closed -$400K – 246
2025
Q1
$400K Buy
+2,867
New +$438K 0.16% 146
2020
Q2
– Sell
-2,224
Closed -$385K – 151
2020
Q1
$385K Buy
2,224
+7
+0.3% +$1.16K 0.34% 90
2019
Q4
$340K Buy
2,217
+6
+0.3% +$897 0.22% 129
2019
Q3
$336K Sell
2,211
-127
-5% -$20.1K 0.23% 129
2019
Q2
$358K Buy
2,338
+10
+0.4% +$1.53K 0.24% 125
2019
Q1
$374K Buy
2,328
+146
+7% +$22.6K 0.26% 123
2018
Q4
$334K Buy
+2,182
New +$340K 0.28% 117

Other funds holding CLX

Roman Butler Fullerton & Co's CLX Position: Q2 2025 in Review

Roman Butler Fullerton & Co sold out of Clorox (CLX) in Q2 2025, closing a stake of 2,867 shares — an estimated $400K sold.

Roman Butler Fullerton & Co first reported a position in CLX in Q4 2018 and held it in 7 quarters. The position peaked at $400K in Q1 2025. 1,126 funds tracked by Wall St. Rank hold CLX as of Q2 2025.

  • Roman Butler Fullerton & Co reported no remaining Clorox position as of Q2 2025 after selling out during the quarter.
  • Roman Butler Fullerton & Co sold 2,867 Clorox shares in Q2 2025, an estimated $400K.
  • Roman Butler Fullerton & Co first reported a position in Clorox in Q4 2018 and held it in 7 quarters.
  • Roman Butler Fullerton & Co's Clorox position peaked at $400K in Q1 2025.
  • 1,126 funds tracked by Wall St. Rank held Clorox as of Q2 2025.

Based on Roman Butler Fullerton & Co's 13F filing for Q2 2025, filed 30 Jul 2025.